IGFBP5 and cancer: Further investigation characterizing the role of proteolytic enzymes in regulating the aberrant activation or degradation of IGFBP5 in cancer is needed to better understand the role of the individual subdomains of IGFBP5, as is proteomic analysis of patient derived samples that quantify the relative abundance of various IGFBP5 fragments relative to the intact protein.